Search

Nemolizumab-ilto (Nemluvio; Galderma) for Prurigo Nodularis

Nemolizumab-ilto (Nemluvio; Galderma) is a subcutaneously injected interleukin-31 receptor antagonist indicated for the treatment of adults with prurigo nodularis.

Complete this form to request the full report